Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bile acid sequestration in the intestine is the process of binding bile acids within the gastrointestinal tract to prevent their reabsorption and promote their fecal excretion. This is the mechanism of action of bile acid sequestrants, which are used to lower LDL cholesterol levels and treat bile acid malabsorption. The process disrupts enterohepatic circulation, prompting increased hepatic bile acid synthesis from cholesterol, resulting in reduced serum cholesterol.
Bile acid sequestrants bind to bile acids in the intestinal lumen, preventing their reabsorption and promoting their excretion in feces. This leads to increased hepatic synthesis of bile acids from cholesterol, ultimately lowering serum LDL cholesterol levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile Acid Sequestration (Intestinal).